학술논문
Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test
Document Type
Article
Author
Source
In: RMD Open . (RMD Open, 10 April 2024, 10(2))
Subject
Language
English
ISSN
20565933